Results 151 to 160 of about 89,248 (335)

Phytochemical, In Silico, In Vitro, and In Vivo Research on Piptadeniastrum africanum (Fabaceae) Unveiling Anti‐Stereotypic, Anxiolytic, and Analgesic Effects in a Sodium Valproate‐Induced Autistic Disorders Model

Brain and Behavior
Objective Individuals with autistic spectrum disorders (ASD) primarily exhibit deficits in communication and social interaction, along with repetitive behaviors and restricted interests.
Ambani Omgba Jeanne Julie, Ngouateu Omer Bébé, Mengue Ngadena Yolande Sandrine, Owona Pascal Emmanuel, Kandeda Kavaye Antoine, Ambamba Akamba Bruno Dupon, Nongni Piebeng Quentin Cicilien, Ngang Nguema Franck Emmanuel, Ngondi Judith Laure, Bilanda Danielle Claude, Dzeufiet Djomeni Paul Désiré   +10 more
doaj   +1 more source

Differential Psychopharmacology of Anxiolytics and Sedatives

, 1981
Max Fink
openalex   +1 more source

Psychedelics, entactogens and psychoplastogens for depression and related disorders

British Journal of Pharmacology, EarlyView.
Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley   +1 more source

Effects of intracerebrally administered anxiolytics on conflict behavior in rats

, 1984
Kazuhiko Shibata, Kimihiro Yamashita, Tohru Ozaki, Showa Ueki   +3 more
openalex   +1 more source

Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?

British Journal of Pharmacology, EarlyView.
Psychedelic drugs that activate 5‐HT2A receptors have been long used for cultural, medicinal and recreational purposes. Interest in psychedelics for treating psychiatric disorders has resurged recently and is well documented; less well recognised are their anti‐inflammatory properties. Growing evidence now demonstrates that psychedelics modulate immune
Omar Qureshi, Jamie Cowley, Ashley Pegg, Alison J. Cooper, John Gordon, Catherine A. Brady, Antonio Belli, Sam Butterworth, Rachel Upthegrove, Nick Andrews, Nicholas M. Barnes   +10 more
wiley   +1 more source

P02.218 Cyamemazine: A revision of its therapeutical anxiolytic profile based on its recently described anti-serotoninergic activity [PDF]

, 2000
Françoise Radat, Ricardo P. Garay, F. d'Alché-Birée, M. Dib   +3 more
openalex   +1 more source

Synthetic microneurotrophins: Neurotrophin receptors for therapeutics of neurodegenerative diseases

British Journal of Pharmacology, EarlyView.
Neurodegenerative disorders are characterised by the chronic progressive degeneration of specific neuronal subtypes, neuroinflammation, myelin damage and synaptic loss. Despite their growing incidence, advancements in effective treatments remain limited, because of lack of knowledge for the aetiology of the diverse pathophysiology to design systematic ...
Ioanna Zota, Theodora Calogeropoulou, Konstantina Chanoumidou, Ioannis Charalampopoulos, Achille Gravanis   +4 more
wiley   +1 more source

Effects of septal lesions on fear-potentiated startle, and on the anxiolytic effects of buspirone and diazepam

, 1991
Kathleen R. Melia, Michael Davis
openalex   +1 more source

Critical insights into the potential risks of antipsychotic drugs to fish, including through effects on behaviour

Biological Reviews, EarlyView.
ABSTRACT Antipsychotic drugs (APDs) are a diverse class of neuroactive pharmaceuticals increasingly detected in surface and ground waters globally. Some APDs are classified as posing a high environmental risk, due, in part, to their tendency to bioaccumulate in wildlife, including fish.
Gabrielle Wasser‐Bennett, A. Ross Brown, Samuel K. Maynard, Stewart F. Owen, Charles R. Tyler   +4 more
wiley   +1 more source

SOME PHYSIOLOGICAL AND NUTRITIONAL RESPONSES OF BROILER CHICKS TO AN ANXIOLYTIC AGENT ADMINSTRATION DURING SUMMER MONTHS. [PDF]

, 2000
I. El-Wardany, G. El- Gendi
openalex   +1 more source